PMC:7228307 / 45151-45238
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 811 | 44-48 | Gene | denotes | FcγR | Gene:2213 | |
| 826 | 58-77 | Disease | denotes | Metabolic disorders | MESH:D008659 | |
| 848 | 23-28 | Mutation | denotes | L234A | p.L234A | |
| 851 | 30-35 | Mutation | denotes | L235A | p.L235A |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T77 | 58-77 | Disease | denotes | Metabolic disorders | http://purl.obolibrary.org/obo/MONDO_0005066 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T793 | 12-15 | http://purl.obolibrary.org/obo/CLO_0052882 | denotes | CD3 |
| T794 | 12-15 | http://purl.obolibrary.org/obo/CLO_0053434 | denotes | CD3 |
| T795 | 44-46 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T232 | 85-87 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T220 | 68-77 | http://purl.obolibrary.org/obo/OGMS_0000045 | denotes | disorders |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes | pubann:has_HGVS_notation |
|---|---|---|---|---|---|---|
| 811 | 44-48 | Gene | denotes | FcγR | Gene:2213 | |
| 826 | 58-77 | Disease | denotes | Metabolic disorders | MESH:D008659 | |
| 848 | 23-28 | Mutation | denotes | L234A | p.L234A | |
| 851 | 30-35 | Mutation | denotes | L235A | p.L235A |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T261 | 0-87 | Sentence | denotes | Teplizumab CD3 IgG1 L234A; L235A Ablate FcγR binding Metabolic disorders Phase II |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T33 | 58-77 | Disease | denotes | Metabolic disorders | http://purl.obolibrary.org/obo/MONDO_0005066 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T261 | 0-87 | Sentence | denotes | Teplizumab CD3 IgG1 L234A; L235A Ablate FcγR binding Metabolic disorders Phase II |